AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi, Ferozsons Laboratories Ltd. (FEROZ), a well-established pharmaceutical company, delivered solid financial results. The share rate closed at Rs. 229.35, closely following the daily weighted average of Rs. 229.21. FEROZ, with a paid-up capital of Rs. 434.69 million, announced a 100% cash dividend, a 50% cash dividend, and a 20% bonus distribution. The company’s EPS for January to November 2023 was Rs. 20.02, with a high of Rs. 240.96. Since its listing in 1961, Ferozsons Laboratories has maintained a strong presence in the Pakistan Stock Exchange.
Check Also
Pakistan Emphasizes Diplomacy for Iran Nuclear Issue
Islamabad: Pakistan has reiterated that the Iran nuclear issue should be addressed through peaceful means. The remarks were made by Pakistan's Permanent Representative to the UN, Asim Iftikhar Ahmad, while speaking on the Security Council Vote on the ...